Navigation Links
Sarcoma Alliance Excited About New Drug Research
Date:6/25/2013

New York, N.Y. (PRWEB) June 25, 2013

The Sarcoma Alliance has high hopes for an experimental drug, TH-302, being studied around the world, Executive Director Arthur Beckert said Tuesday.

"I'm very confident of this drug in sarcoma," said William Tap, MD, section chief for sarcoma oncology at Memorial Sloan-Kettering Cancer Center in New York. There are more than 50 subtypes of sarcoma, a rare cancer of bone, muscle, nerve, fat and other connective tissues. It can arise anywhere in the body, from newborn on up.

He gave an update on TH-302 this month at the American Society of Clinical Oncology’s annual meeting. The first findings may be available next year.

Ninety-five cancer centers in the U.S., Canada, Europe and Israel have signed up for the clinical trial, according to the National Institutes of Health. “Australia is coming aboard soon,” said Dr. Tap, the trial’s principal investigator.

Having this many study sites is amazing, compared with sarcoma research a decade ago, he said. The study is being done by Threshold Pharmaceuticals in conjunction with SARC (Sarcoma Alliance for Research Through Collaboration). SARC, founded in 2003 in Ann Arbor, Mich., brings together physicians and scientists from different institutions to collaborate on research.

(SARC is sometimes confused with the Sarcoma Alliance, which was founded in 1999 in Mill Valley, Calif., to provide information and support to people affected by sarcoma, Beckert said. Both are nonprofits.)

Dr. Tap said 338 patients have enrolled in the TH-302 trial so far, with a goal of 450. In one arm of the phase 3 trial, patients get doxorubicin (Adriamycin) and TH-302. In the other, they get only doxorubicin. Patients are selected at random to go into one arm or the other. He said the trial is enrolling patients who have intermediate- and hig
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools
2. Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma
3. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
4. VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
5. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
6. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
7. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
8. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
9. Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
10. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
11. Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... rather than electricity, to move data would consume ... a growing concern as chips, transistor counts rise. ... circuits light emitters, modulators, and detectors ... light source for optical chips is molybdenum disulfide ... as a single, atom-thick layer. Other experimental on-chip ...
(Date:9/19/2014)... , September 19, 2014 ... technology, development of emerging drug systems and advanced Laboratory ... Dickinson and Company (NYSE: BDX ), Thermo ... Biosciences Inc. (NASDAQ: RGDO ), Sangamo Biosciences ... (NASDAQ: HOLX) Pressure BioSciences, Inc. (OTCQB: PBIO) ...
(Date:9/19/2014)... CORAL SPRINGS, Florida , September 19, 2014 /PRNewswire/ ... biotech companies release latest developments, patents and results of ... (OTC: GNSZ), Eli Lilly and Company (NYSE: ... ), Celgene Corporation (NASDAQ: CELG ) and ... (OTCQB: GNSZ), a leader in developing prodrug therapeutics for ...
(Date:9/19/2014)... , September 19, 2014 ... and Markets ( http://www.researchandmarkets.com/research/b2jxhs/micro_market ) has announced the addition ... Chromatography Columns"  report to their offering.  ... market is one of the fastest-growing segments in ... $1.2 billion in 2013, and expected to reach ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 2Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 3Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 4Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 5Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 6Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 7Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7Micro Market Monitor : Global Pre-packed Chromatography Columns 2
... economic,and business growth in the Tampa Bay Region from the ... Acquires Manufacturing Site in Tampa Bay , ... St. Petersburg recently where it plans to manufacture microchips for ... should be completed,in March 2009. The site could employ ...
... PRINCETON, N.J., Jan. 6 Medarex, Inc. (Nasdaq: ... at the 27th Annual J.P. Morgan Healthcare Conference at 8:30 ... 13, 2009. The event will be webcast live and will ... website at www.medarex.com . An archived edition of the ...
... Biosciences, Inc. announced today that David J. Mazzo, Ph.D., ... the 27th Annual J.P. Morgan Healthcare Conference in San ... Pacific Time (2:30pm Eastern Time). Dr. Mazzo,s presentation ... in development, the REG1 System, its pipeline and enterprise-level ...
Cached Biology Technology:Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 2Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 4Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference 2
(Date:9/18/2014)... new GSA Bulletin study uses tree rings ... and Chaco Wash in northern New Mexico, USA. By ... and willow, investigators were able to precisely date arroyo ... combined this data with aerial imagery, LiDAR, longitudinal profiles, ... arroyos. , Arroyos are deep, oversized channels that have ...
(Date:9/18/2014)... researchers from McGill University and the Quebec government ... ,microbeads, Canadian Journal of Fisheries and Aquatic ... cosmetics, household cleansers, or industrial cleansers, to which ... their small size and buoyancy, they may readily ... a global contaminant in the world,s oceans, but ...
(Date:9/18/2014)... in DNA, tiny strands of nucleic acid that contain ... this genetic data, our DNA is copied into RNA ... perform tasks in our cells. , Several years ... Unlike all other known RNAs, this molecule is circular, ... abundant, little has been known about how they are ...
Breaking Biology News(10 mins):Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Microplastic pollution discovered in St. Lawrence River sediments 2Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2
... In the last decade, a new strain of MRSA has ... risk of contracting the dangerous bacterial infection. This particular strain ... of genes not shared by any other strains, though it ... to survive and persist in the community. Now, research ...
... The rate of chemical processes in cells is dictated by ... given reaction. Using a versatile method developed at the Institute ... Warsaw, researchers were able to predict for the first time ... . The achievement is important not only for biologists and ...
... the original Otom inhabitants of Xaltocan, the capital of ... long wondered whether they assimilated with the Aztecs or ... research from The University of Texas at Austin, Wichita ... lie in DNA. Following this line of evidence, the ...
Cached Biology News:UNC study may lead to treatments that are effective against all MRSA strains 2Biologistics: How fast do chemical trains move in living cells? 2Biologistics: How fast do chemical trains move in living cells? 3Aztec conquest altered genetics among early Mexico inhabitants, new DNA study shows 2